insitro is Drug Discovery in United States that focus on data-driven drug business. Founded in 2018. They cover business area such as operator, drug, patient, machine learning, high-throughput biology, massive datum set, key bottleneck, pharmaceutical r&d, predictive model, target selection, effective therapeutic, clinical strategy.
2018
( 6 years old in 2024 )
Data-driven Drug
-
279 East Grand Avenue
Suite 200
San Francisco, CA 94080
United States
Private
operatordrugpatientmachine learninghigh-throughput biologymassive datum setkey bottleneckpharmaceutical r&dpredictive modeltarget selectioneffective therapeuticclinical strategy
* We use standard office opening hours in near insitro's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Insitro is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), insitro business is focusing on Data-driven Drug.
insitro headquarter office and corporate office address is located in 279 East Grand Avenue Suite 200 San Francisco, CA 94080 United States.
insitro was founded in United States.
In 2024, insitro is currently focus on data-driven drug sector.
Above is snippet of Google Trends for "data-driven drug" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with insitro, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
